NANOBIOTIX Provides Business Update and Reports Full Year
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel...
Source: globenewswire.com
📰 Advanced Head News
Advanced Head News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Advanced Head. Real-time updates on events, politics, business and more.
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV expands worldwide potential of novel radioenhancer NBTXR3Prolonged survival in Study 102 reinforces...
Source: marketscreener.com
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel radioenhancer NBTXR3Prolonged survival in Study 102 reinforces pivotal NANORAY-312 trial design in head and
Source: eagletribune.com
NANOBIOTIX Provides Third Quarter 2023 Operational and Financial Update
$2.5 billion global licensing, co-development, and commercialization agreement expands worldwide potential of novel radioenhancer NBTXR316.9 months median progression free survival (mPFS) and 23.1 months median overall survival (mOS) following radiotherapy-activated
Source: elpasoinc.com
Gilead and Kite Oncology Present Important New Data Across Multiple Difficult-to-Treat Cancers at ESMO Congress 2023
– Real-World Evidence and New Clinical Analysis Support the Role of Trodelvy® in Metastatic Breast Cancers – – New Data Demonstrate Potential of Trodelvy in Small Cell Lung Cancer,...
Source: marketscreener.com
NANOBIOTIX Provides Business Update and Financial Results for the First Half of 2023
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel r...
Source: businessinsider.com
NANOBIOTIX Provides Business Update and Financial Results
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel...
Source: globenewswire.com
GeoVax Receives Notice of Allowance for Malaria Vaccine Patent
28.08.2023 - Patent Covers Multiple Component Vaccine for Both Prevention and Treatment ATLANTA, GA, Aug. 28, 2023 (GLOBE NEWSWIRE) - via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines ... Seite 1
Source: wallstreet-online.de
NANOBIOTIX Provides First Quarter 2023 Operational and Financial Update
Reported €30.2 million in cash and cash equivalents as of March 31, 2023PARIS and CAMBRIDGE, Mass., May 17, 2023 -- NANOBIOTIX , a late-clinical stage biotechnology company pioneering... | May 17, 2023
United Kingdom France General United States Nord Pas De Calais New York University Of Texas Md Anderson Cancer Center
Source: marketscreener.com
Head and neck cancer specialist joins SMH
SARASOTA (SNN TV) – Sarasota Memorial Health Care System is welcoming the first dedicated head and neck cancer and microvascular surgeon to First Physicians Group (FPG) network and the team of s
Peter Vosler Johns Hopkins University School Of Medicine Johns Hopkins University School Neck Surgery Advanced Head Neck Cancer
Source: snntv.com